Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-05

Clinical Trial Update: NBMI - Clinical Study on COPD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NBMI in chronic obstructive pulmonary disease and COPD bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NBMI

Snippet

Sponsor: EmeraMed | Conditions: COPD, COPD Bronchitis | Phase 2 | Status: COMPLETED